AAD 2026 Late-Breaker: Lawrence Eichenfield, MD, on Phase 2 Success of Nemolizumab in Pediatric AD

Dermatology Times·Mar 28

This story is reported by Dermatology Times. Read what other outlets are saying below, then open the original report for full details.